Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis Zhang HL; Wu J; Zhu JClin Dev Immunol 2010[]; 2010 (ä): 186813Apolipoprotein E (apoE) is a 34.2 kDa glycoprotein characterized by its wide tissue distribution and multiple functions. The nonlipid-related properties of apoE include modulating inflammation and oxidation, suppressing T cell proliferation, regulating macrophage functions, and facilitating lipid antigen presentation by CD1 molecules to natural killer T (NKT) cells, and so forth. Increasing studies have revealed that APOE epsilon allele might be associated with multiple sclerosis (MS), although evidence is still not sufficient enough. In this review, we summarized the current progress of the immunomodulatory functions of apoE, with special focus on the association of APOE epsilon allele with the clinical features of MS and of its animal model experimental autoimmune encephalomyelitis (EAE).|*Immunomodulation[MESH]|Animals[MESH]|Apolipoproteins E/genetics/immunology/*metabolism[MESH]|Autoimmunity[MESH]|Biomarkers/metabolism[MESH]|Encephalomyelitis, Autoimmune, Experimental/*genetics/*immunology/physiopathology[MESH]|Genetic Predisposition to Disease[MESH]|Humans[MESH]|Mice[MESH]|Multiple Sclerosis/*genetics/*immunology/physiopathology[MESH]|Oxidation-Reduction[MESH]|Polymorphism, Genetic[MESH] |